ELTROVE INSIDERS

WALSH COLIN

Director

1 filing on record here, covering ATTO. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.

Filings

CORPORATEFiled 2026-08-13
BuyATTOAttovia Therapeutics, Inc.$1,785,000
SellATTOAttovia Therapeutics, Inc.$21,766
SellATTOAttovia Therapeutics, Inc.$9,776
SellATTOAttovia Therapeutics, Inc.$29,344
SellATTOAttovia Therapeutics, Inc.$4,410
SellATTOAttovia Therapeutics, Inc.$34,325
SellATTOAttovia Therapeutics, Inc.$74,912
SellATTOAttovia Therapeutics, Inc.$4,420
SellATTOAttovia Therapeutics, Inc.$10,344
SellATTOAttovia Therapeutics, Inc.$2,211
SellATTOAttovia Therapeutics, Inc.$16,543
SellATTOAttovia Therapeutics, Inc.$14,797
SellATTOAttovia Therapeutics, Inc.$153,549
SellATTOAttovia Therapeutics, Inc.$8,808
Source filing
See the latest filings from everyone
Source records are public filings: House and Senate periodic transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts are reported as ranges by law, not exact figures, and filings arrive on a legal delay. Eltrove reports what was filed. Nothing here is investment advice or a recommendation.